Tag Archives: Mesothelioma

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More: FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First… »

First Mesothelioma Treatment in 15 Years Approved

May 24, 2019 — The FDA has approved the first new treatment in 15 years for an aggressive form of lung cancer. The device, the NovoTTF-100L System made by Novocure, uses electric fields to stop solid tumors from mesothelioma from dividing. Mesothelioma is a rare but aggressive cancer strongly associated with asbestos exposure. The new… Read More: First Mesothelioma Treatment in 15 Years Approved »

Mesothelioma: The Working Man’s Killer

by United Nations Photo Back in the day, asbestos was used in the construction of many buildings and places of business. Unknowing workers worked in these structures each day not know that there was danger lurking in the walls and ceiling. Some years later, they were diagnosed with a type of lung cancer that was… Read More: Mesothelioma: The Working Man’s Killer »